Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sophiris Bio Inc SPHS

Healthcare Biotechnology
Sophiris Bio Inc is a clinical-stage biopharmaceutical company. It focuses on the development of products for the treatment of urological diseases. The company's product portfolio includes topsalysin (PRX302), for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. Topsalysin is... see more

Recent & Breaking News (EXPM:SPHS)

15 Biggest Mid-Day Gainers For Friday

Benzinga.com  March 24, 2017

16 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  March 24, 2017

Topsalysin Data from Successful Phase 2a Localized Prostate Cancer Study to be Presented at the 32nd European Association of Urology Congress

PR Newswire March 23, 2017

Sophiris Bio to Present at 29th Annual ROTH Conference

PR Newswire March 6, 2017

How These Generic Drugs Stocks are Faring? -- Diplomat Pharmacy, Momenta Pharma, Agile Therapeutics, and Sophiris Bio

PR Newswire March 2, 2017

Sophiris Bio to Webcast Live Presentation at BetterInvesting's Virtual Investor Conference

PR Newswire January 30, 2017

Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present February 2nd

PR Newswire January 30, 2017

How These Generic Drugs Stocks are Faring? -- Catalyst Pharma, Sophiris Bio, Momenta Pharma, and Agile Therapeutics

PR Newswire January 23, 2017

Healthcare Stocks on Investors' Radar -- Sophiris Bio, Catalyst Pharma, Neurocrine Biosciences, and Capital Senior Living

PR Newswire December 13, 2016

20 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  November 29, 2016

Sophiris Bio to Present at 28th Annual Piper Jaffray Healthcare Conference

PR Newswire November 22, 2016

Sophiris Bio Reports Third Quarter 2016 Financial Results and Key Business Highlights

PR Newswire November 9, 2016

Generic Drugs Stocks on Investors' Radar -- Zoetis, Sophiris Bio, Rigel Pharma, and Mallinckrodt

PR Newswire October 28, 2016

Sophiris Bio to Present at the 2016 BIO Investor Forum

PR Newswire October 10, 2016

15 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  August 30, 2016

Sophiris Bio Closes Underwritten Public Offering

PR Newswire August 26, 2016

12 Biggest Mid-Day Losers For Wednesday

Benzinga.com  August 24, 2016

Mid-Afternoon Market Update: Crude Oil Up 1.5%; Tableau Software Shares Climb Following News Of New CEO

Benzinga.com  August 23, 2016

Sophiris Bio Prices Public Offering of Common Shares and Warrants

PR Newswire August 23, 2016

20 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  August 23, 2016